Want to join the conversation?
$TROW sold certain available-for-sale holdings during 1Q16 and used the proceeds to provide seed capital to new and existing sponsored products in support of its distribution efforts outside the US. The investment income on consolidated sponsored investment portfolios rose as the number of portfolios consolidated rose significantly.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.